Home/Filings/4/0001140361-07-024882
4//SEC Filing

LYONDELL CHEMICAL CO 4

Accession 0001140361-07-024882

CIK 0000842635operating

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 2:06 PM ET

Size

34.5 KB

Accession

0001140361-07-024882

Insider Transaction Report

Form 4
Period: 2007-12-20
HOLLINSHEAD JOHN A
Vice President
Transactions
  • Award

    Common Stock

    2007-12-20+28,52963,671 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$31.75/sh30,924$981,8370 total
    Exercise: $16.25Exp: 2011-02-01Common Stock (30,924 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$34.20/sh30,962$1,058,9000 total
    Exercise: $13.80Exp: 2012-02-08Common Stock (30,962 underlying)
  • Disposition to Issuer

    Common Stock

    2007-12-2027,9120 total(indirect: By 401(k))
  • Disposition to Issuer

    Common Stock

    2007-12-203,0000 total(indirect: See Footnote)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$30.45/sh19,988$608,6350 total
    Exercise: $17.55Exp: 2014-02-05Common Stock (19,988 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$23.48/sh24,906$584,7930 total
    Exercise: $24.52Exp: 2016-02-23Common Stock (24,906 underlying)
  • Disposition to Issuer

    Phantom Stock

    2007-12-20$48.00/sh5,958$285,9840 total
    Common Stock (5,958 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$19.44/sh17,246$335,2620 total
    Exercise: $28.56Exp: 2015-01-20Common Stock (17,246 underlying)
  • Disposition to Issuer

    Common Stock

    2007-12-2035,1420 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$35.13/sh54,430$1,912,1260 total
    Exercise: $12.87Exp: 2013-02-07Common Stock (54,430 underlying)
  • Disposition to Issuer

    Common Stock

    2007-12-20$48.00/sh28,529$1,369,39235,142 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$16.03/sh27,702$444,0630 total
    Exercise: $31.97Exp: 2017-02-22Common Stock (27,702 underlying)
Footnotes (11)
  • [F1]This reports the payout of performance awards denominated in shares of Lyondell?s common stock, on the effective date of the merger pursuant to the Merger Agreement between Lyondell and Basell and BIL Acquisition Holdings Limited (?Merger Agreement?) for the merger consideration of $48 per share.
  • [F10]The options, which vested on the effective date of the merger, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $444,063.06 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F11]Phantom Stock which convert on a 1 for 1 basis and provided for vesting in 3 equal annual installments beginning one year from the date of grant, was disposed of on the effective date of the merger pursuant to the Merger Agreement for the merger consideration of $48 per share.
  • [F2]Shares of common stock disposed of on the effective date of the merger pursuant to the Merger Agreement for the merger consideration of $48 per share.
  • [F3]Includes: (1) 2,000 shares of common stock held by a family limited partnership. The general partner of the family limited partnership is a company owned by Mr. Hollinshead; and (2) 1,000 shares of Lyondell common stock in a jointly-owned account owned by Mr. Hollinshead along with other persons. Mr. Hollinshead disclaims beneficial ownership of these 1,000 shares except to the extent of his pecuniary interest in the shares.
  • [F4]The options, 1/3 which vested on February 1, 2002 and 2/3 which vested on August 21, 2002 in connection with Lyondell's purchase of Occidental Petroleum Corporation's interest in Equistar Chemicals, LP, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $981,837.00 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F5]The options, 2/3 which vested ratably on February 8, 2003 and February 8, 2004 and 1/3 vested on December 1, 2004 in connection with the acquisition of Millennium Chemicals Inc., were canceled pursuant to the Merger Agreement in exchange for a cash payment of $1,058,900.40 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F6]The options, 1/3 which vested on February 7, 2007 and 2/3 on November 23, 2004 because the Lyondell common stock price became two times the exercise price of the stock option, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $1,912,125.90 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F7]The options, which vested on December 1, 2004 in connection with the acquisition of Millennium Chemicals Inc., were canceled pursuant to the Merger Agreement in exchange for a cash payment of $608,634.60 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F8]The options, which 2/3 vested ratably on January 20, 2006 and January 20, 2007 and 1/3 vested on November 20, 2007 in connection with shareholder approval of the merger, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $335,262.24 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F9]The options, which 1/3 vested on February 23, 2007 and the remaining 2/3 on the effective date of the merger, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $584,792.88 representing the difference between the exercise price of the option and the $48 per share merger consideration.

Documents

1 file

Issuer

LYONDELL CHEMICAL CO

CIK 0000842635

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000842635

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 2:06 PM ET
Size
34.5 KB